![The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study | Modern Pathology The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.2010.102/MediaObjects/41379_2010_Article_BFmodpathol2010102_Fig1_HTML.jpg)
The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study | Modern Pathology
Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining
![Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals](https://images.novusbio.com/images2/Melanoma-Marker-(MART-1-+-Tyrosinase-+-gp100)-Antibody-(A103-+-T311-+-HMB45)-Flow-(Intracellular)-NBP2-34339-img0003.jpg)
Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals
![Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals Melanoma Marker (MART-1 + Tyrosinase + gp100) Antibody (A103 + T311 + HMB45) (NBP2-34339): Novus Biologicals](https://images.novusbio.com/images2/Melanoma-Marker-(MART-1-+-Tyrosinase-+-gp100)-Antibody-(A103-+-T311-+-HMB45)-Western-Blot-NBP2-34339-img0004.jpg)